Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지

Profiling of Differentially Expressed Genes in Human Cervical Carcinoma

  • Lee, Seung-Hoon (Department of Biological Science, YongIn university) ;
  • Shim, Chan-Sub (Department of Obstetrics and Gynecology, Samsung Medical Center) ;
  • Lee, Je-Ho (Department of Obstetrics and Gynecology, Samsung Medical Center)
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Using the DDRT-PCR, a series of differentially expressed genes in human primary cervical cancer was isolated. Among the 250 PCR amplimers, 88 gene fragments were confirmed by reverse Northern hybridization. Homology searches indicated that 26 out of 88 were previously known genes including calmodulin, human BBC1, histone H3.3, a series of ribosomal proteins (RPL19, RPS19, and RPS12), translation initiation factor (eIF-4AI), lactoferrin, integrin ${\alpha}6$, cell-surface antigens (CD9 and CD59), transcription factor (mbp-1), and mitochondrial proteins. Several unknown clones showed sequence homology with known genes. Furthermore, six of the unknown genes showed identical sequence with expressed sequence tags (EST) of unknown function. Differential expression patterns of identified genes were further examined and confirmed with multiple pairs of cervical cancer samples using Northern hybridization. Our profiling of differentially expressed genes may provide useful information about the underlying genetic alterations in human cervical carcinoma and diagnostic markers for this disease. The precise roles of these genes in cancer development remain to be elucidated.

Keywords

References

  1. Atkin NB, Baker MC, and Fox MF (1990) Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genetics Cytogenet 44: 229-241 https://doi.org/10.1016/0165-4608(90)90052-C
  2. Bezault J, Bhimani R, Wiprovnick J, and Furmanski P (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54: 2310-2312
  3. Cajot JF, Sordat I, Silvestre T, and Sordat B (1997) Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57: 2593-2597
  4. Chunming L and Raghothama KG (1996) Practical method for cloning cDNAs generated in an mRNA differential display. Biotechnol 20: 576-580
  5. Davis B and Fried M (1995) The L19 ribosomal protein gene (RPL19): gene organization, chromosomal mapping, and novel promoter region. Genomics 25: 372-380 https://doi.org/10.1016/0888-7543(95)80036-L
  6. De Benedetti A and Rhoads RE (1990) Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 87: 8212-8216 https://doi.org/10.1073/pnas.87.21.8212
  7. Drobni P, Naslund J, and Evander M (2004) Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res 64(1):63-68
  8. Furuya M, Kato H, Nishimura N, Ishiwata I, Ikeda H, Ito R, Yoshiki T, and Ishikura H (2005) Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta 1 integrin subsets. Cancer Res 65(7):2617-2625 https://doi.org/10.1158/0008-5472.CAN-04-3123
  9. Henry JL, Coggin DL, and King CR (1993) High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 53: 1403-1408
  10. Higashiyama M, Doi O, Kodama K, Yolouchi H, Adachi M, Huang CL, Taki T, Kasugai T, Ishiguro S, Nakamori S, and Miyake M (1997) Immunohistochemically detected expression of motility-related protein-l (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 74: 205-211 https://doi.org/10.1002/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C
  11. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, Kodama K., Doi O, and Miyake M (1995) Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55: 6040-6044
  12. Hurley WL, Hegarty HM, and Metzler JT (1994) In vitro inhibition of mammary cell growth by lactoferrin: a comparative study. Life Sci 55: 1955-1963 https://doi.org/10.1016/0024-3205(94)00528-1
  13. Ikonomov OC and Jacob MH (1996) Differential display protocol with selected primers that preferentially isolates mRNAs of moderate- to low-abundance in a microscopic system. Biotechnol 20: 1030-1042
  14. Jones PH, Bishop LA, and Watt FM (1996) Functional significance of CD9 association with b1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4: 297-305 https://doi.org/10.3109/15419069609010773
  15. Kondoh N, Schweinfest CW, Henderson KW, and Papas TS (1992) Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52: 791-796
  16. Kusukawa J, Ryu F, Kameyama T, and Mekada E (2001) Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metstasis. J Oral Pathol Med 30(2):73-79 https://doi.org/10.1034/j.1600-0714.2001.300202.x
  17. Liang P and Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971 https://doi.org/10.1126/science.1354393
  18. Liang P, Averbouk K, Keymarsi K, and Sager R (1992) Differential display and cloning of mRNAs from human breast cancer versus mammary epithelial cells. Cancer Res 52: 6966-6968
  19. Lorincz AT, Temple GF, Kurman, R.J, Jenson AB, and Lancaster WD (1987) Oncogenic association of specific human papilloma virus types with cervical neoplasia. J Int Cancer Inst 79: 671-677
  20. Maecker HT, Todd SC, and Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB J 11:428-442
  21. Manolaraki MM, Arvanitis DA, Sourvinos G, Sifakis S, Koumantakis E, Spandidos DA (2002) Frequent loss of heterozygosity in chromosomal region 9pter-p13 in tumor biopsies and cytological material of uterine cervical cancer. Cancer letter 176(2):175-181 https://doi.org/10.1016/S0304-3835(01)00750-9
  22. McMaster MT, Teng CT, Dey SK, and Andrews GK (1992) Lactoferrin in the mouse uterus: analysis of the preimplantation period and regulation by ovarian steroids. Mol Endocrinol 6: 101-111 https://doi.org/10.1210/me.6.1.101
  23. Miyake M, Nakano K., Ieki Y, Adachi M, Huang CL, Itoi S, Koh T, and Taki T (1995) Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55: 4127-4131
  24. Newbold RR, Teng CT, Beckman WC, Jr Jefferson WN, Hanson RB, Miller JV, and Mclachlan JA (1992) Fluctuations of 1actoferrin protein and messenger ribonucleic acid in the reproductive tract of the mouse during the estrous cycle. Biol Reprod 47: 903-915 https://doi.org/10.1095/biolreprod47.5.903
  25. Ocadiz R, Sauceda R, Cruz M, Graef AM, and Gariglio P (1987) High correlations between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 47: 4173-4177
  26. Park TW, Fujiwara H, and Wright TC (1995) Molecualr biology of cervical cancer and its precursors. Cancer Supplement 76: 1902-1913 https://doi.org/10.1002/1097-0142(19951115)76:10+<1902::AID-CNCR2820761306>3.0.CO;2-0
  27. Riou G, Barrois M, Sheng ZM, Duvillard P, and Lhomme C (1988) Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3: 329-333
  28. Salehi Z, Mashavekhi F (2006) Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in Esophageal cancer. Clin Biochem. 39(4):404-409 https://doi.org/10.1016/j.clinbiochem.2005.11.007
  29. Sambrook J, Fritsch EF, and Maniatis T (1989) Molecular cloning: A Laboratory Manual. New York NY Cold Spring Harbor Press
  30. Scheffner M, Munger K, Huibregtse JM, and Howley PM (1992) Targeted degradation of the retinoblastoma protein by human apillomavirus E7-E6 fusion proteins. EMBO J 11: 2425-2431
  31. Scheffner M, Wemess BA, Huibregtse JM, Levine AJ, and Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136 https://doi.org/10.1016/0092-8674(90)90409-8
  32. Shim CS, Zhang W, Rhee CH, and Lee J-H (1998) Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 4:3045-3050
  33. Steekantaiah C, Bhargava KK, and Shetty JJ (1988) Chromosome I abnormalities in cervical carcinoma. Cancer 62: 1317-1324 https://doi.org/10.1002/1097-0142(19881001)62:7<1317::AID-CNCR2820620713>3.0.CO;2-K
  34. Susa M, Olivier AR, Fabbro D, and Thomas G (1989) EGF induces biphasic S6 kinase activation: Late phase is protein kinase C-dependent and contributes to mitogenicity. Cell 57: 817-824 https://doi.org/10.1016/0092-8674(89)90796-4
  35. Teng CT, Pentecost BT, Chen YH, Newbold RR, Eddy EM, and McLachlan JA (1989) Lactotransferrin gene expression in the mouse uterus and mammary gland. Endocrinology 124: 992-999 https://doi.org/10.1210/endo-124-2-992
  36. Walmer DK, Padin CJ, Wrona MA, Healy BE, Bentley RC, Tsao MS, Kohler MF, McLachlan JA, and Gray KD (1995) Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res 55: 1168-1175
  37. Wang M, Hu Y,and Steams ME (2009) RPS2: a novel therapeutic target in prostate cancer. J Exp Clin Cancer Res. 28:6 https://doi.org/10.1186/1756-9966-28-6
  38. Wong JM, Mafune K, Yow H, Rivers EN, Ravikumar TS, Steele GO, and Jr Chen LB (1993) Ubiquitin-ribosomal protein S27a gene overexpressed in human colorectal carcinoma is an early growth response gene. Cancer Res 53: 1916-1920